Single dose partial breast irradiation using an MRI linear accelerator in the supine and prone treatment position.

Published online

Journal Article

Background: In selected patients with early-stage and low-risk breast cancer, an MRI-linac based treatment might enable a radiosurgical, non-invasive alternative for current standard breast conserving therapy. Aim: To investigate whether single dose accelerated partial breast (APBI) to the intact tumor in both the prone and supine radiotherapy positions on the MRI-linac is dosimetrically feasible with respect to predefined coverage and organs at risk (OAR) constraints. Material & methods: For 20 patients with cTis or low-risk cT1N0M0 non-lobular breast carcinoma, previously treated with single dose preoperative APBI in the supine (n = 10) or prone (n = 10) position, additional intensity modulated radiotherapy plans with 7 coplanar beams in the presence of a 1.5T magnetic field were generated. A 20 Gy and 15 Gy dose was prescribed to the gross tumor and clinical target volume, respectively. The percentage of plans achieving predefined organ at risk (OAR) constraints, currently used in clinical practice, was assessed. Dosimetry differences between the prone versus supine approach and the MRI-linac versus clinically delivered plans were evaluated. Results: All MRI-linac plans met the coverage and predefined OAR constraints. The prone approach appeared to be more favorable with respect to the chest wall, and ipsilateral lung dose compared to the supine position. No dosimetric differences were observed for the ipsilateral breast. No treatment position was clearly more beneficial for the skin or heart, since dosimetry varied among parameters. Overall, the MRI-linac and clinical plans were comparable, with minor absolute dosimetric differences. Conclusion: MRI-linac based single dose APBI to the intact tumor is a promising and a dosimetrically feasible strategy in patients with low-risk breast cancer. Preliminary OAR dosimetry favored the prone radiotherapy position.

Full Text

Duke Authors

Cited Authors

  • Charaghvandi, KR; Van't Westeinde, T; Yoo, S; Houweling, AC; Rodrigues, A; Verkooijen, HM; Philippens, MEP; van Asselen, B; Horton, JK; van den Bongard, HJGD

Published Date

  • January 2019

Published In

Volume / Issue

  • 14 /

Start / End Page

  • 1 - 7

PubMed ID

  • 30406210

Pubmed Central ID

  • 30406210

Electronic International Standard Serial Number (EISSN)

  • 2405-6308

Digital Object Identifier (DOI)

  • 10.1016/j.ctro.2018.09.001


  • eng

Conference Location

  • Ireland